Penumbra, Inc. (PEN)
324.07
+0.32
(+0.10%)
USD |
NYSE |
Aug 25, 10:16
Penumbra EPS Diluted (Quarterly) : 0.8797 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8797 |
| March 31, 2026 | 0.824 |
| December 31, 2025 | 1.202 |
| September 30, 2025 | 1.167 |
| June 30, 2025 | 1.154 |
| March 31, 2025 | 1.002 |
| December 31, 2024 | 0.8628 |
| September 30, 2024 | 0.7537 |
| June 30, 2024 | -1.552 |
| March 31, 2024 | 0.2793 |
| December 31, 2023 | 1.380 |
| September 30, 2023 | 0.2349 |
| June 30, 2023 | 0.4837 |
| March 31, 2023 | 0.2191 |
| December 31, 2022 | 0.0997 |
| September 30, 2022 | -0.0599 |
| June 30, 2022 | -0.0976 |
| March 31, 2022 | 0.002 |
| December 31, 2021 | -0.6577 |
| September 30, 2021 | 0.2353 |
| June 30, 2021 | 0.2456 |
| March 31, 2021 | 0.3153 |
| December 31, 2020 | 0.0974 |
| September 30, 2020 | -0.2435 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.3378 |
| March 31, 2020 | 0.0392 |
| December 31, 2019 | 0.2668 |
| September 30, 2019 | 0.3166 |
| June 30, 2019 | 0.458 |
| March 31, 2019 | 0.2954 |
| December 31, 2018 | 0.1842 |
| September 30, 2018 | -0.5527 |
| June 30, 2018 | 0.37 |
| March 31, 2018 | 0.15 |
| December 31, 2017 | 0.25 |
| September 30, 2017 | 0.01 |
| June 30, 2017 | -0.05 |
| March 31, 2017 | -0.10 |
| December 31, 2016 | -0.08 |
| September 30, 2016 | 0.35 |
| June 30, 2016 | 0.09 |
| March 31, 2016 | 0.07 |
| December 31, 2015 | 0.0304 |
| September 30, 2015 | 0.03 |
| June 30, 2015 | -0.0175 |
| March 31, 2015 | 0.0206 |
| June 30, 2014 | 0.0024 |
| March 31, 2014 | 0.0115 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.615 |
| Globus Medical, Inc. | 1.103 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Teleflex, Inc. | 2.283 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 34.81M |
| Revenue (Quarterly) | 390.05M |
| Total Expenses (Quarterly) | 355.24M |
| Enterprise Value | 12.31B |
| Gross Profit Margin (Quarterly) | 66.50% |
| Profit Margin (Quarterly) | 8.92% |
| Earnings Yield | 1.26% |
| Operating Earnings Yield | 1.47% |
| Normalized Earnings Yield | 1.257 |